SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018787
Filing Date
2024-05-13
Accepted
2024-05-13 08:00:46
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 542182
2 ex31-1.htm EX-31.1 12741
3 ex31-2.htm EX-31.2 12788
4 ex31-3.htm EX-31.3 12748
5 ex32-1.htm EX-32.1 11188
  Complete submission text file 0001493152-24-018787.txt   3471778

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cocp-20240331.xsd EX-101.SCH 30757
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cocp-20240331_cal.xml EX-101.CAL 39739
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cocp-20240331_def.xml EX-101.DEF 112318
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cocp-20240331_lab.xml EX-101.LAB 264025
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cocp-20240331_pre.xml EX-101.PRE 199374
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 422269
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 24936941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)